I reckon that the pandemic is a overhyped falsity, as evidenced by:
- Mainly old and chronically ill people being affected by the 'deadly' disease
- Flu cases going away during the period of Covid
- CDC admitting that the PCR tests can't differentiate between influenza and Covid
I asked about your take on specifically the 600k+ US deaths attributed to Covid and what percentage you think is false attribution? Just ballpark it. Something more specific than just an "overhyped falsity".
As for your third bullet, "CDC admitting that the PCR tests can't differentiate between influenza and Covid," that seems to be an actual overhyped falsity and a major misinterpretation.
From the Kaiser Foundation:
Claims That CDC’s PCR Test Can’t Tell Covid From Flu Are Wronghttps://khn.org/news/article/fact-check-cdc-pcr-covid-test-distinguishes-from-flu-eua-request-withdrawal/There' a lot of info in the article that shows these FB meme claims to be demonstratively false. I'll try to summarize the gist, but do read the full article. It's not long but covers off quite comprehensively on why the meme claims are bunk.
The CDC requested the FDA cancel the EUA for the original PCR assay/protocol they published (not manufactured) in Feb 2020 in lieu of introducing a new PCR assay that tests for not only Covid but various Influenza viruses as well.
In short, it's not that the original PCR tests couldn't differentiate between Covid and Influenza strains it's that it
ONLY tested for Covid and Covid alone. The thinking now by the CDC with the new assay is that it actually looks for and differentiates between Covid AND various Influenza strains as they feel it's more important, more efficient, more cost effective to have one assay for Covid
AND Influenza.
"
In the lab alert, the CDC said it was withdrawing the EUA request because, rather than testing only for the covid virus, it wants labs to test people for multiple viruses simultaneously, using what is known as a “multiplexed method.” The CDC’s 2019-nCoV RT-PCR panel tests only for the covid virus.
“Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season,” noted the alert regarding the multiplexed method."
“
They didn’t withdraw the EUA because the test wasn’t working,” said Whittier. “They just wanted people to look for other viruses as well.” Whittier is Dr. Susan Whittier, PhD, a professor of pathology and cell biology at Columbia University Irving Medical Center.